• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性多血管性冠状动脉疾病患者血清 C1q 结合型脂联素复合物与总脂联素比值升高。

Increased serum C1q-binding adiponectin complex to total-adiponectin ratio in men with multi-vessel coronary disease.

机构信息

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan ; Kishida Clinic, Toyonaka, Osaka, Japan.

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.

出版信息

Diabetol Metab Syndr. 2014 May 27;6:64. doi: 10.1186/1758-5996-6-64. eCollection 2014.

DOI:10.1186/1758-5996-6-64
PMID:24883115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4038830/
Abstract

BACKGROUND

Adiponectin plays a role as a positive contributor to the stabilization of atherosclerotic plaques. Circulating total adiponectin (Total-APN) levels associates with the number of coronary vessels in men with coronary artery disease (CAD). We recently reported that adiponectin binds to C1q in human blood, and serum C1q-binding adiponectin (C1q-APN) /Total-APN levels are associated with CAD in type 2 diabetic subjects. The present study investigated the relationship between circulating C1q-APN levels and the number of angiographic coronary artery vessel in male subjects.

METHODS

The study subjects were 53 male Japanese patients who underwent diagnostic coronary angiography. Blood total adiponectin (Total-APN), high-molecular weight adiponectin (HMW-APN), C1q-APN and C1q were measured by enzyme-linked immunosorbent assays.

RESULTS

Serum C1q-APN/Total-APN ratio significantly increased in subjects with single and multi-vessel coronary diseases (p = 0.029 for trend, the Kruskal-Wallis test). However, serum Total-APN, HMW-APN, C1q-APN and C1q levels did not correlate with number of diseased coronary vessels.

CONCLUSION

Serum C1q-APN/Total-APN ratio progressively increases in men with single and multi-vessel coronary disease.

TRIAL REGISTRATION

UMIN000002997.

摘要

背景

脂联素在稳定动脉粥样硬化斑块方面发挥积极作用。循环总脂联素(Total-APN)水平与冠心病(CAD)男性患者冠状动脉血管数量有关。我们最近报道,脂联素在人血液中与 C1q 结合,血清 C1q 结合脂联素(C1q-APN)/总脂联素(Total-APN)水平与 2 型糖尿病患者的 CAD 相关。本研究探讨了循环 C1q-APN 水平与男性患者血管造影冠状动脉血管数量之间的关系。

方法

本研究对象为 53 名接受诊断性冠状动脉造影的日本男性患者。通过酶联免疫吸附试验测定血液总脂联素(Total-APN)、高分子量脂联素(HMW-APN)、C1q-APN 和 C1q。

结果

单支和多支病变冠状动脉疾病患者血清 C1q-APN/Total-APN 比值显著升高(Kruskal-Wallis 检验趋势,p=0.029)。然而,血清 Total-APN、HMW-APN、C1q-APN 和 C1q 水平与病变冠状动脉血管数量无关。

结论

患有单支和多支病变冠状动脉疾病的男性患者血清 C1q-APN/Total-APN 比值逐渐升高。

试验注册

UMIN000002997。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aeb/4038830/74875b6f0e0a/1758-5996-6-64-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aeb/4038830/6556631f2d7e/1758-5996-6-64-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aeb/4038830/74875b6f0e0a/1758-5996-6-64-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aeb/4038830/6556631f2d7e/1758-5996-6-64-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aeb/4038830/74875b6f0e0a/1758-5996-6-64-2.jpg

相似文献

1
Increased serum C1q-binding adiponectin complex to total-adiponectin ratio in men with multi-vessel coronary disease.男性多血管性冠状动脉疾病患者血清 C1q 结合型脂联素复合物与总脂联素比值升高。
Diabetol Metab Syndr. 2014 May 27;6:64. doi: 10.1186/1758-5996-6-64. eCollection 2014.
2
High serum C1q-adiponectin/total adiponectin ratio correlates with coronary artery disease in Japanese type 2 diabetics.高血清 C1q-脂联素/总脂联素比值与日本 2 型糖尿病患者的冠状动脉疾病相关。
Metabolism. 2013 Apr;62(4):578-85. doi: 10.1016/j.metabol.2012.10.011. Epub 2012 Nov 20.
3
The amount of C1q-adiponectin complex is higher in the serum and the complex localizes to perivascular areas of fat tissues and the intimal-medial layer of blood vessels of coronary artery disease patients.在血清中,C1q-脂联素复合物的含量更高,并且该复合物定位于脂肪组织的血管周围区域以及冠心病患者血管的内膜-中层。
Cardiovasc Diabetol. 2015 May 9;14:50. doi: 10.1186/s12933-015-0209-0.
4
Correlation of circulating C1q and C1q-binding adiponectin concentrations with aging in males: a preliminary report.循环 C1q 和 C1q 结合脂联素浓度与男性衰老的相关性:初步报告。
Diabetol Metab Syndr. 2013 Mar 27;5(1):17. doi: 10.1186/1758-5996-5-17.
5
Serum C1q- binding adiponectin in maintenance hemodialysis patients.维持性血液透析患者血清 C1q 结合型脂联素。
BMC Nephrol. 2013 Feb 26;14:50. doi: 10.1186/1471-2369-14-50.
6
High serum C1q-binding adiponectin levels in male patients with acute coronary syndrome.急性冠状动脉综合征男性患者血清中C1q结合脂联素水平较高。
Cardiovasc Diabetol. 2014 Jan 9;13:9. doi: 10.1186/1475-2840-13-9.
7
Correlation between serum C1q-adiponectin/total adiponectin ratio and polyvascular lesions detected by vascular ultrasonography in Japanese type 2 diabetics.血清 C1q-脂联素/总脂联素比值与日本 2 型糖尿病患者血管超声检测到的多血管病变的相关性。
Metabolism. 2013 Mar;62(3):376-85. doi: 10.1016/j.metabol.2012.08.009. Epub 2012 Oct 9.
8
Circulating levels of adiponectin and extent of coronary artery disease in patients undergoing elective coronary angiography.接受择期冠状动脉造影术患者的脂联素循环水平与冠状动脉疾病程度
Braz J Med Biol Res. 2017 Nov 30;51(2):e6738. doi: 10.1590/1414-431X20176738.
9
Binding of adiponectin and C1q in human serum, and clinical significance of the measurement of C1q-adiponectin / total adiponectin ratio.人血清中脂联素与 C1q 的结合,以及 C1q-脂联素/总脂联素比值测定的临床意义。
Metabolism. 2013 Jan;62(1):109-20. doi: 10.1016/j.metabol.2012.06.006. Epub 2012 Jul 21.
10
Gender-Specific Associations between Circulating T-Cadherin and High Molecular Weight-Adiponectin in Patients with Stable Coronary Artery Disease.稳定型冠状动脉疾病患者循环中T-钙黏蛋白与高分子量脂联素之间的性别特异性关联
PLoS One. 2015 Jun 17;10(6):e0131140. doi: 10.1371/journal.pone.0131140. eCollection 2015.

引用本文的文献

1
The Role of Anti-Inflammatory Adipokines in Cardiometabolic Disorders: Moving beyond Adiponectin.抗炎脂肪因子在心脏代谢紊乱中的作用:超越脂联素。
Int J Mol Sci. 2021 Dec 16;22(24):13529. doi: 10.3390/ijms222413529.

本文引用的文献

1
Adiponectin as a routine clinical biomarker.脂联素作为一种常规临床生物标志物。
Best Pract Res Clin Endocrinol Metab. 2014 Jan;28(1):119-30. doi: 10.1016/j.beem.2013.08.006. Epub 2013 Aug 20.
2
High serum C1q-binding adiponectin levels in male patients with acute coronary syndrome.急性冠状动脉综合征男性患者血清中C1q结合脂联素水平较高。
Cardiovasc Diabetol. 2014 Jan 9;13:9. doi: 10.1186/1475-2840-13-9.
3
Predictive value of adiponectin in patients with multivessel coronary atherosclerosis detected on computed tomography angiography.
计算机断层血管造影术检测到多支冠状动脉粥样硬化患者脂联素的预测价值。
J Atheroscler Thromb. 2013;20(10):767-76. doi: 10.5551/jat.18036. Epub 2013 Jun 13.
4
Serum C1q- binding adiponectin in maintenance hemodialysis patients.维持性血液透析患者血清 C1q 结合型脂联素。
BMC Nephrol. 2013 Feb 26;14:50. doi: 10.1186/1471-2369-14-50.
5
High serum C1q-adiponectin/total adiponectin ratio correlates with coronary artery disease in Japanese type 2 diabetics.高血清 C1q-脂联素/总脂联素比值与日本 2 型糖尿病患者的冠状动脉疾病相关。
Metabolism. 2013 Apr;62(4):578-85. doi: 10.1016/j.metabol.2012.10.011. Epub 2012 Nov 20.
6
Three-month treatment with pioglitazone reduces circulating C1q-binding adiponectin complex to total-adiponectin ratio, without changes in body mass index, in people with type 2 diabetes.吡格列酮治疗 3 个月可降低 2 型糖尿病患者循环 C1q 结合型脂联素复合物与总脂联素的比值,而体重指数无变化。
Diabetes Res Clin Pract. 2013 Jan;99(1):e14-7. doi: 10.1016/j.diabres.2012.10.003. Epub 2012 Nov 9.
7
Correlation between serum C1q-adiponectin/total adiponectin ratio and polyvascular lesions detected by vascular ultrasonography in Japanese type 2 diabetics.血清 C1q-脂联素/总脂联素比值与日本 2 型糖尿病患者血管超声检测到的多血管病变的相关性。
Metabolism. 2013 Mar;62(3):376-85. doi: 10.1016/j.metabol.2012.08.009. Epub 2012 Oct 9.
8
Binding of adiponectin and C1q in human serum, and clinical significance of the measurement of C1q-adiponectin / total adiponectin ratio.人血清中脂联素与 C1q 的结合,以及 C1q-脂联素/总脂联素比值测定的临床意义。
Metabolism. 2013 Jan;62(1):109-20. doi: 10.1016/j.metabol.2012.06.006. Epub 2012 Jul 21.
9
Serum adiponectin and leptin as predictors of the presence and degree of coronary atherosclerosis.血清脂联素和瘦素作为冠状动脉粥样硬化存在及程度的预测指标。
Coron Artery Dis. 2011 Jun;22(4):264-9. doi: 10.1097/MCA.0b013e3283452431.
10
Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes.在日本2型糖尿病患者中,使用吡格列酮进行为期三个月的治疗可降低硫代巴比妥酸反应物质(一种反应性氧化应激标志物)的循环水平,且体重指数无变化。
Atherosclerosis. 2010 Sep;212(1):243-5. doi: 10.1016/j.atherosclerosis.2010.05.025. Epub 2010 May 24.